{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:29:14Z","timestamp":1791286154714,"version":"4.1.0"},"reference-count":180,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00362","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T04:29:05Z","timestamp":1551673745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":190,"title":["Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System"],"prefix":"10.3389","volume":"10","author":[{"given":"Sarah M.","family":"Carpanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Torvell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","article-title":"Blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier in normal and pathological conditions","volume":"33","author":"Ueno","year":"2016","journal-title":"Brain Tumor Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.it.2006.11.004","article-title":"What is immune privilege (not)?","volume":"28","author":"Galea","year":"2007","journal-title":"Trends Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","article-title":"CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature","volume":"21","author":"Louveau","year":"2018","journal-title":"Nat Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.celrep.2016.12.041","article-title":"Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain","volume":"18","author":"Askew","year":"2017","journal-title":"Cell Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","article-title":"C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages","volume":"42","author":"Hoeffel","year":"2015","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.immuni.2015.07.016","article-title":"Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells","volume":"43","author":"Sheng","year":"2015","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","article-title":"The microglial sensome revealed by direct RNA sequencing","volume":"16","author":"Hickman","year":"2013","journal-title":"Nat Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fncel.2013.00034","article-title":"Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair","volume":"7","author":"London","year":"2013","journal-title":"Front Cell Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.expneurol.2017.08.011","article-title":"Microglia and macrophages differ in their inflammatory profile after permanent brain ischemia","volume":"301","author":"Zarruk","year":"2018","journal-title":"Exp Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1017\/S146114570800967X","article-title":"Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration","volume":"12","author":"O'Sullivan","year":"2009","journal-title":"Int J Neuropsychopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nn.4222","article-title":"Microglial brain region-dependent diversity and selective regional sensitivities to aging","volume":"19","author":"Grabert","year":"2016","journal-title":"Nat Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1126\/science.aal3222","article-title":"An environment-dependent transcriptional network specifies human microglia identity","volume":"356","author":"Gosselin","year":"2017","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.163.3864.286","article-title":"Human C'3: evidence for the liver as the primary site of synthesis","volume":"163","author":"Alper","year":"1969","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/glia.10234","article-title":"Expression of complement messenger RNAs and proteins by human oligodendroglial cells","volume":"42","author":"Hosokawa","year":"2003","journal-title":"Glia"},{"key":"B24","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.155.10.4882","article-title":"Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes","volume":"155","author":"Gasque","year":"1995","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1365-2567.1996.d01-756.x","article-title":"Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes","volume":"89","author":"Gasque","year":"1996","journal-title":"Immunology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jnr.490400407","article-title":"Complement and cytokine gene expression in cultured microglial derived from postmortem human brains","volume":"40","author":"Walker","year":"1995","journal-title":"J Neurosci Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/intimm\/12.7.1015","article-title":"Expression of a complete and functional complement system by human neuronal cells in vitro","volume":"12","author":"Thomas","year":"2000","journal-title":"Int Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/exnr.1999.7199","article-title":"Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor","volume":"160","author":"Veerhuis","year":"1999","journal-title":"Exp Neurol."},{"key":"B29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s004019570001","article-title":"Early complement components in Alzheimer's disease brains","volume":"91","author":"Veerhuis","year":"1996","journal-title":"Acta Neuropathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0169-328X(92)90017-6","article-title":"Complement gene expression in human brain: comparison between normal and Alzheimer disease cases","volume":"14","author":"Walker","year":"1992","journal-title":"Brain Res Mol Brain Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.devcel.2011.10.012","article-title":"Complement fragment C3a controls mutual cell attraction during collective cell migration","volume":"21","author":"Carmona-Fontaine","year":"2011","journal-title":"Dev Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15096","DOI":"10.1038\/ncomms15096","article-title":"Developmental activities of the complement pathway in migrating neurons","volume":"8","author":"Gorelik","year":"2017","journal-title":"Nat Commun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0896-6273(03)00608-1","article-title":"Mechanisms of synapse assembly and disassembly","volume":"40","author":"Goda","year":"2003","journal-title":"Neuron"},{"key":"B34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nn1218","article-title":"Neural activity and the dynamics of central nervous system development","volume":"7","author":"Hua","year":"2004","journal-title":"Nat Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2013.12.013","article-title":"Altered cognitive performance and synaptic function in the hippocampus of mice lacking C3","volume":"253","author":"Perez-Alcazar","year":"2014","journal-title":"Exp Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"13029","DOI":"10.1523\/JNEUROSCI.1698-15.2015","article-title":"Complement C3-deficient mice fail to display age-related hippocampal decline","volume":"35","author":"Shi","year":"2015","journal-title":"J Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7975","DOI":"10.1073\/pnas.0913449107","article-title":"Enhanced synaptic connectivity and epilepsy in C1q knockout mice","volume":"107","author":"Chu","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"B41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139","author":"DiSabato","year":"2016","journal-title":"J Neurochem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/14737175.2017.1282821","article-title":"Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases","volume":"17","author":"Pilch","year":"2017","journal-title":"Expert Rev Neurother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12026-017-8961-8","article-title":"The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis","volume":"65","author":"Tatomir","year":"2017","journal-title":"Immunol Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12974-018-1066-z","article-title":"The role of the complement system in traumatic brain injury: a review","volume":"15","author":"Hammad","year":"2018","journal-title":"J Neuroinflamm."},{"key":"B45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0165-5728(96)00164-6","article-title":"Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury","volume":"73","author":"Kossmann","year":"1997","journal-title":"J Neuroimmunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/neup.12320","article-title":"Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury","volume":"37","author":"Troakes","year":"2017","journal-title":"Neuropathology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/089771501316919139","article-title":"Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury","volume":"18","author":"Stahel","year":"2001","journal-title":"J Neurotrauma."},{"key":"B48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00701-010-0737-z","article-title":"Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B","volume":"153","author":"Bellander","year":"2011","journal-title":"Acta Neurochirurgica"},{"key":"B49","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3171\/jns.1996.85.3.0468","article-title":"Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat","volume":"85","author":"Bellander","year":"1996","journal-title":"J Neurosurg."},{"key":"B50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbr.2016.08.058","article-title":"Protein profiling in serum after traumatic brain injury in rats reveals potential injury markers","volume":"340","author":"Thelin","year":"2018","journal-title":"Behav Brain Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jneuroim.2004.06.003","article-title":"Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist","volume":"155","author":"Sewell","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/sj.jcbfm.9600497","article-title":"Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4","volume":"27","author":"You","year":"2007","journal-title":"J Cereb Blood Flow Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1742-2094-11-95","article-title":"Deficiency of complement receptors CR2\/CR1 in Cr2(-)\/(-) mice reduces the extent of secondary brain damage after closed head injury","volume":"11","author":"Neher","year":"2014","journal-title":"J Neuroinflammation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2202-7-55","article-title":"Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation","volume":"7","author":"Leinhase","year":"2006","journal-title":"BMC Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"13876","DOI":"10.1523\/JNEUROSCI.2823-08.2008","article-title":"Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury","volume":"28","author":"Galvan","year":"2008","journal-title":"J Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.2353\/ajpath.2010.100158","article-title":"The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury","volume":"177","author":"Qiao","year":"2010","journal-title":"Am J Pathol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am J Pathol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nbd.2014.02.008","article-title":"Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice","volume":"66","author":"Li","year":"2014","journal-title":"Neurobiol Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease","volume":"24","author":"Fonseca","year":"2004","journal-title":"J Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.0829-08.2008","article-title":"Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia\/macrophage phenotype in amyloid precursor protein transgenic mice","volume":"28","author":"Maier","year":"2008","journal-title":"J Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice","author":"Shi","year":"2017","journal-title":"Sci Transl Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"E4385","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"Chiu","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B65","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1073\/pnas.1321248111","article-title":"Role for terminal complement activation in amyotrophic lateral sclerosis disease progression","volume":"111","author":"Woodruff","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JHD-2012-120021","article-title":"Genetic deficiency of complement component 3 does not alter disease progression in a mouse model of Huntington's disease","volume":"1","author":"Larkin","year":"2012","journal-title":"J Huntingtons Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.brainres.2007.08.033","article-title":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","volume":"1178","author":"Liang","year":"2007","journal-title":"Brain Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.05.006","article-title":"Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease","volume":"236","author":"Depboylu","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","article-title":"Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway","volume":"14","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1097\/CCM.0000000000000399","article-title":"Mannose-binding lectin is expressed after clinical and experimental traumatic brain injury and its deletion is protective","volume":"42","author":"Longhi","year":"2014","journal-title":"Crit Care Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/sj.jcbfm.9600605","article-title":"Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice","volume":"28","author":"Yager","year":"2008","journal-title":"J Cereb Blood Flow Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/jcbfm.1995.107","article-title":"Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats","volume":"15","author":"Kaczorowski","year":"1995","journal-title":"J Cereb Blood Flow Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1742-2094-4-13","article-title":"Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice","volume":"4","author":"Leinhase","year":"2007","journal-title":"J Neuroinflammation"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.4049\/jimmunol.1302793","article-title":"Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice","volume":"192","author":"Fluiter","year":"2014","journal-title":"J Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"14319","DOI":"10.1073\/pnas.1513698112","article-title":"An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice","volume":"112","author":"Ruseva","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B76","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0271678X16647397","article-title":"Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury","volume":"37","author":"De Blasio","year":"2017","journal-title":"J Cereb Blood Flow Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/08977150260139093","article-title":"Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury","volume":"19","author":"Hicks","year":"2002","journal-title":"J Neurotrauma"},{"key":"B78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sc.2009.104","article-title":"Soluble complement receptor type 1 inhibits complement system activation and improves motor function in acute spinal cord injury","volume":"48","author":"Li","year":"2010","journal-title":"Spinal Cord"},{"key":"B79","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1196\/annals.1332.011","article-title":"Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury","volume":"1035","author":"Reynolds","year":"2004","journal-title":"Ann NY Acad Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1179\/174313208X284241","article-title":"Protective effect of C1 esterase inhibitor on acute traumatic spinal cord injury in the rat","volume":"30","author":"Tei","year":"2008","journal-title":"Neurol Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's disease","volume":"36","author":"Lian","year":"2016","journal-title":"J Neurosci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis","volume":"181","author":"Woodruff","year":"2008","journal-title":"J Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.expneurol.2006.01.033","article-title":"Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury","volume":"199","author":"Leinhase","year":"2006","journal-title":"Exp Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/01.WCB.0000084250.20114.2C","article-title":"Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice","volume":"23","author":"Rancan","year":"2003","journal-title":"J Cereb Blood Flow Metab."},{"key":"B89","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-3-211-85578-2_73","article-title":"Neuroprotective effect of C1-inhibitor following traumatic brain injury in mice","volume":"102","author":"Longhi","year":"2008","journal-title":"Acta Neurochir Suppl."},{"key":"B90","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/CCM.0b013e318195998a","article-title":"C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice","volume":"37","author":"Longhi","year":"2009","journal-title":"Crit Care Med."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2197-17.2018","article-title":"Identifying the role of complement in triggering neuroinflammation after traumatic brain injury","author":"Alawieh","year":"2018","journal-title":"J Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.spinee.2003.07.007","article-title":"Pathophysiology and pharmacologic treatment of acute spinal cord injury","volume":"4","author":"Kwon","year":"2004","journal-title":"Spine J."},{"key":"B93","first-page":"335","article-title":"Proteins of the complement system and acute phase reactants in sera of patients with spinal cord injury","volume":"66","author":"Rebhun","year":"1991","journal-title":"Ann Allergy"},{"key":"B94","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0306-4522(95)00103-P","article-title":"Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat","volume":"68","author":"Liu","year":"1995","journal-title":"Neuroscience"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1089\/neu.2004.21.1831","article-title":"Activation of complement pathways after contusion-induced spinal cord injury","volume":"21","author":"Anderson","year":"2004","journal-title":"J Neurotrauma"},{"key":"B96","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/neu.2005.22.382","article-title":"Upregulation of complement inhibitors in association with vulnerable cells following contusion-induced spinal cord injury","volume":"22","author":"Anderson","year":"2005","journal-title":"J Neurotrauma"},{"key":"B97","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"J Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1523\/JNEUROSCI.4473-12.2015","article-title":"Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo","volume":"35","author":"Peterson","year":"2015","journal-title":"J Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/jnr.10821","article-title":"Treatment with the neurosteroid dehydroepiandrosterone promotes recovery of motor behavior after moderate contusive spinal cord injury in the mouse","volume":"75","author":"Fiore","year":"2004","journal-title":"J Neurosci Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1602\/neurorx.1.1.80","article-title":"Neuroprotection and acute spinal cord injury: a reappraisal","volume":"1","author":"Hall","year":"2004","journal-title":"NeuroRx"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.2174\/1381612053507404","article-title":"Neuroprotection and regeneration strategies for spinal cord repair","volume":"11","author":"Tsai","year":"2005","journal-title":"Curr Pharmaceut Design"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/infdis\/166.6.1245","article-title":"Regulation of complement activity by vaccinia virus complement-control protein","volume":"166","author":"McKenzie","year":"1992","journal-title":"J Infect Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1385\/IR:26:1-3:007","article-title":"Complement in central nervous system inflammation","volume":"26","author":"Barnum","year":"2002","journal-title":"Immunol Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"Neuromolecular Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/jpet.105.086835","article-title":"Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease","volume":"314","author":"Woodruff","year":"2005","journal-title":"J Pharmacol Exp Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"key":"B108","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: the rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.wad.0000165511.52746.1f","article-title":"Association between dementia and infectious disease: evidence from a case-control study","volume":"19","author":"Dunn","year":"2005","journal-title":"Alzheimer Dis Assoc Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet."},{"key":"B113","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer's disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B114","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-160420","article-title":"Complement biomarkers as predictors of disease progression in Alzheimer's disease","volume":"54","author":"Hakobyan","year":"2016","journal-title":"J Alzheimers Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-016-0277-8","article-title":"CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease","volume":"4","author":"Hu","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"B116","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-160889","article-title":"The correlation between inflammatory biomarkers and polygenic risk score in Alzheimer's disease","volume":"56","author":"Morgan","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jalz.2018.07.223","article-title":"An updated Alzheimer hypothesis: complement C3 and risk of Alzheimer's disease-a cohort study of 95,442 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"B118","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/BF00687336","article-title":"Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques","volume":"63","author":"Ishii","year":"1984","journal-title":"Acta Neuropathol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc Natl Acad Sci USA."},{"key":"B120","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00192116","article-title":"Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3","volume":"426","author":"Veerhuis","year":"1995","journal-title":"Virchows Arch."},{"key":"B121","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","article-title":"Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease","volume":"18","author":"Webster","year":"1997","journal-title":"Neurobiol Aging"},{"key":"B122","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1742-2094-10-25","article-title":"Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology","volume":"10","author":"Fonseca","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B123","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1742-2094-9-179","article-title":"Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study","volume":"9","author":"Cribbs","year":"2012","journal-title":"J Neuroinflammation"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","article-title":"Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease","volume":"106","author":"Zhou","year":"2008","journal-title":"J Neurochem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","article-title":"A dramatic increase of C1q protein in the CNS during normal aging","volume":"33","author":"Stephan","year":"2013","journal-title":"J Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1084\/jem.188.3.431","article-title":"Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide","volume":"188","author":"Bradt","year":"1998","journal-title":"J Exp Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1759091416687871","DOI":"10.1177\/1759091416687871","article-title":"C5a increases the injury to primary neurons elicited by fibrillar amyloid beta","volume":"9","author":"Hernandez","year":"2017","journal-title":"ASN Neuro"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","article-title":"Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"158","author":"Matsuoka","year":"2001","journal-title":"Am J Pathol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1074\/jbc.M112.400168","article-title":"C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-\u03b2 neurotoxicity","volume":"288","author":"Benoit","year":"2013","journal-title":"J Biol Chem."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.neuron.2018.10.031","article-title":"Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer's disease","volume":"100","author":"Litvinchuk","year":"2018","journal-title":"Neuron"},{"key":"B132","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1091581817740873","article-title":"Nonclinical development of ANX005: a humanized anti-C1q antibody for treatment of autoimmune and neurodegenerative diseases","volume":"36","author":"Lansita","year":"2017","journal-title":"Int J Toxicol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B134","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35097565","article-title":"From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat Rev Neurosci."},{"key":"B135","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu Rev Neurosci."},{"key":"B136","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/PL00005241","article-title":"Riluzole, a glutamate release inhibitor, and motor behavior","volume":"358","author":"Kretschmer","year":"1998","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2004.01.019","article-title":"Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)","volume":"125","author":"Wang","year":"2004","journal-title":"Neuroscience"},{"key":"B138","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"B139","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0165-5728(84)90042-0","article-title":"Deposits of IgG and C3 in the spinal cord and motor cortex of ALS patients","volume":"6","author":"Donnenfeld","year":"1984","journal-title":"J Neuroimmunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol Dis."},{"key":"B141","first-page":"691","article-title":"Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata","year":"1992","journal-title":"Am J Pathol."},{"key":"B142","first-page":"393","article-title":"Innate immunity in ALS","volume-title":"Amyotrophic Lateral Sclerosis","author":"Lee","year":"2012"},{"key":"B143","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0304-3940(90)90196-G","article-title":"Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d","volume":"112","author":"Yamada","year":"1990","journal-title":"Neurosci Lett."},{"key":"B144","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B145","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"T\u00fcz\u00fcn","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B146","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/B978-0-12-386986-9.00004-1","article-title":"Neurovascular aspects of amyotrophic lateral sclerosis","volume":"102","author":"Rodrigues","year":"2012","journal-title":"Int Rev Neurobiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(99)00496-6","article-title":"C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis","volume":"271","author":"Grewal","year":"1999","journal-title":"Neurosci Lett."},{"key":"B148","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1600-0404.1985.tb01548.x","article-title":"High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients","volume":"72","author":"Annunziata","year":"1985","journal-title":"Acta Neurol Scand."},{"key":"B149","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-0404.1991.tb04656.x","article-title":"Serum and CSF immunological findings in ALS","volume":"83","author":"Apostolski","year":"1991","journal-title":"Acta Neurol Scand."},{"key":"B150","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/jnnp.57.7.859","article-title":"Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis","volume":"57","author":"Tsuboi","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B151","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J Neuroimmunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"B153","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.conb.2011.05.029","article-title":"Understanding the role of TDP-43 and FUS\/TLS in ALS and beyond","volume":"21","author":"Da Cruz","year":"2011","journal-title":"Curr Opin Neurobiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J Neuroinflammation"},{"key":"B155","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1073\/pnas.0702230104","article-title":"Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons","volume":"104","author":"Lobsiger","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B156","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J Neuroimmunol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","article-title":"Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis","volume":"15","author":"Lee","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B158","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B159","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"B160","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"B161","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J Neuropathol Exp Neurol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"B164","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp Neurol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet."},{"key":"B166","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J Proteome Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.bbrc.2007.04.055","article-title":"Complement activation by islet amyloid polypeptide (IAPP) and alpha-synuclein 112","volume":"357","author":"Klegeris","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s004010000225","article-title":"Activated microglial cells and complement factors are unrelated to cortical Lewy bodies","volume":"100","author":"Rozemuller","year":"2000","journal-title":"Acta Neuropathol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J Neuroinflammation"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ajpath.2011.01.006","article-title":"Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy","volume":"178","author":"Wang","year":"2011","journal-title":"Am J Pathol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","article-title":"Parkinson's disease mouse models in translational research","volume":"22","author":"Antony","year":"2011","journal-title":"Mamm Genome"},{"key":"B173","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrd4657","article-title":"Complement, a target for therapy in inflammatory and degenerative diseases","volume":"14","author":"Morgan","year":"2015","journal-title":"Nat Rev Drug Discov."},{"key":"B174","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/10717544.2013.878858","article-title":"Strategies for drug delivery to the central nervous system by systemic route","volume":"22","author":"Kasinathan","year":"2015","journal-title":"Drug Deliv."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","article-title":"Overcoming the blood-brain tumor barrier for effective glioblastoma treatment","volume":"19","author":"van Tellingen","year":"2015","journal-title":"Drug Resist Updat"},{"key":"B177","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1021\/bc060349x","article-title":"Fusion antibody for Alzheimer's disease with bidirectional transport across the blood\u2013 brain barrier and A\u03b2 Fibril disaggregation","volume":"18","author":"Boado","year":"2007","journal-title":"Bioconjugate Chem."},{"key":"B178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","author":"Gordon","year":"2018","journal-title":"Sci Transl Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","article-title":"Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study","volume":"12","author":"Pittock","year":"2013","journal-title":"Lancet Neurol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","article-title":"A review of fluid biomarkers for Alzheimer's disease: moving from csf to blood","volume":"6","author":"Blennow","year":"2017","journal-title":"Neurol Ther."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00362\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T03:58:50Z","timestamp":1694663930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00362\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":180,"alternative-id":["10.3389\/fimmu.2019.00362"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00362","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"article-number":"362"}}